Filing Details

Accession Number:
0001127602-18-001879
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-16 17:42:42
Reporting Period:
2018-01-11
Accepted Time:
2018-01-16 17:42:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334682 H Gregg Alton Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Evp Comm&Acs Ala, Corp&Med Aff No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-11 7,501 $24.91 57,114 No 4 M Direct
Common Stock Acquisiton 2018-01-11 18,374 $40.56 75,488 No 4 M Direct
Common Stock Disposition 2018-01-11 7,501 $79.00 67,987 No 4 S Direct
Common Stock Disposition 2018-01-11 18,374 $79.00 49,613 No 4 S Direct
Common Stock Disposition 2018-01-11 4,125 $79.00 45,488 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2018-01-11 7,501 $0.00 7,501 $24.91
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2018-01-11 18,374 $0.00 18,374 $40.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-07-29 No 4 M Direct
90,096 2023-02-01 No 4 M Direct
Footnotes
  1. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
  2. The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
  3. The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.